A Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition

The present invention is directed to a Zika virus (ZIKV) chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition. The present invention provides means, in particular polynucleotides, vectors and cells expressing said chimeric polyepitope. The present inventi...

Full description

Saved in:
Bibliographic Details
Main Authors DELGADO, Felix, SAKUNTABHAI, Anavaj, SIMON-LORIERE, Etienne, ROTH, Claude
Format Patent
LanguageEnglish
Published 23.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to a Zika virus (ZIKV) chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition. The present invention provides means, in particular polynucleotides, vectors and cells expressing said chimeric polyepitope. The present invention also relates to a composition or a vaccine comprising at least one of said polyepitope, polynucleotide, vector or host cell for use in the prevention of a ZIKV infection in a human subject, or for use in the prevention of ZIKV and dengue virus (DENV) infections in a human subject.
Bibliography:Application Number: AU20180365296